DOCSLIB.ORG

Re-Instated Items

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Re-Instated Items Re-Instated Items Smith # Sz Description NDC/UPC Manufacturer 331959 1ct Clonazepam .5mg 100ct 30228300311 Actavis/Teva 085415 1ct Clonazepam .5mg 500ct 30228300350 Actavis/Teva 332114 1ct Clonazepam 1mg 100ct 30228300411 Actavis/Teva 085795 1ct Clonazepam 2mg 500ct 30228300550 Actavis/Teva 247544 1ct Coppertone Lot SPF8 8oz 04110008181 Bayer Direct 841924 1ct Morning After Tab 36995351401 CB Distributors 590638 1ct EOS Lot Purse Pak Everyday Scent 6ct 89299200243 EOS Products 808899 1ct Benztropine Tab 1mg 100ct 30603243821 Par Pharmaceuticals 394254 1ct Methocarbamol Tab 500mg 100ct 30603448521 Par Pharmaceuticals 299909 1ct Dimetapp DM C/C Elix AF 4oz 30031223413 Pfizer Consumer 621391 1ct Liothyronine Sod Tab 5mcg 100ct 34279401802 Sigmapharma 621367 1ct Liothyronine Sod Tab 25mcg 100ct 34279401902 Sigmapharma 621383 1ct Liothyronine Sod Tab 50mcg 100ct 34279402002 Sigmapharma 584441 1ct Irbesartan Tab 150mg 30ct 30093746556 Teva Pharma 124792 1ct Ester C 500mg Coated Tablets 60ct 02507716970 US Nutrition 197731 1ct SD Folic Acid Tab 400mcg 250ct 03076804069 US Nutrition 766428 1ct SD Co-Q-10 400mg Softgel 30ct 03076813338 US Nutrition 612572 1ct SD Red Krill Oil 1000mg Softgel 60ct 03076829545 US Nutrition 752667 1ct SD Probiotic Balance Caps 30ct 03076854047 US Nutrition 427823 1ct NB Fish Oil 1200mg Ent Sofgel 60ct 07431216887 US Nutrition 567222 1ct NB Mini Fish Oil 1290mg Sofgel 90ct 07431218678 US Nutrition 702530 1ct NB Krill Oil 500mg Softgels 30ct 07431251239 US Nutrition 667493 1ct SD Garcinia Cambogia 1000mg 90ct 03076854074 US Nutrition 574590 1ct Meperidine vl 50mg/1ml 1ml 25ct 30641605325 West-Ward Pharma 068296 1ct Dexamethasone Tab 1mg 100ct 30054418125 West-Ward Pharma 280040 1ct Dexamethasone 1.5mg Pnk 100ct 30054418225 West-Ward Pharma Spartanburg, SC & Valdosta, GA Paragould, AR Toll Free 800-572-1216 Toll Free 866-346-9147 6/11/2018 Discontinued Items ct Smith # Sz Description NDC/UPC Manufacturer 705426 1ct Spironolactone Tab 25mg 100ct 30228280311 Actavis/Teva Pharm 705434 1ct Spironolactone Tab 25mg 500ct 30228280350 Actavis/Teva Pharm 833582 1ct Spironolactone Tab 50mg 100ct 30228267211 Actavis/Teva Pharm 322529 1ct Spironolactone Tab 100mg 100ct 30228267311 Actavis/Teva Pharm 779710 1ct Fosinopril/HCTZ Tab 20/12.5mg 100ct 35723702701 Citron Pharma LLC 349209 1ct Ibuprofen Tab 400mg 500ct 35511168205 Dr Reddy’s Labs 357087 1ct Ibuprofen Tab 600mg 500ct 35511168305 Dr Reddy’s Labs 363887 1ct Ibuprofen Tab 800mg 500ct 35511168405 Dr Reddy’s Labs 360644 1ct Ibuprofen Tab 800mg 100ct 35511168401 Dr Reddy’s Labs 352195 1ct Ibuprofen Tab 400mg 100ct 35511168201 Dr Reddy’s Labs 751081 1ct Cyproheptadine Tab 4mg 1000ct 36472015011 Impax Generics 596916 1ct Axert Tab 6.25mg 6’s Blisterpack 35045821101 Janssen 783332 1ct Methylphenidate Sol 5mg/5ml 500sol 34338693005 Lupin/Narc 783340 1ct Methylphenidate Sol 10mg/5ml 500sol 34338693105 Lupin/Narc 074864 1ct Nitro-Dur Discs .2mg/hr 30ct 30085331030 MSD/Merck 652495 1ct Ranitidine Tab 150mg 100ct 35166035101 Ohm Laboratories 161554 1ct Prednisolone Syr 15mg/5ml 473ml 30603156758 Par Pharmaceutical 453217 1ct Triamcinolone Lot .1% 60ml 30603786449 Par Pharmaceutical 737528 1ct Triamcinolone Cr .025% 15gm 30603786174 Par Pharmaceutical 520726 1ct Triamcinolone Cr .1% 80gm 30603786290 Par Pharmaceutical 505966 1ct Thermacare Pad Lo Back/Hip 1ct 30573301001 Pfizer Consumer 669606 1ct Emergen-C Immune+Apple Cider 10ct 88589800033 Pfizer Consumer 669549 1ct Chap Stick Hydrat Lock Day/Nit .155z 30573196110 Pfizer Consumer 841197 1ct Mothers Day Candle Set Lavendar 84009311134 Piping Rock 841205 1ct Mothers Day Candle Set Calming 84009311135 Piping Rock 284018 1ct Handshield 5oz Tube 75026370305 Stanmar Labs 287516 1ct Handshield Diabetic Hand Cream 5oz 75026360005 Stanmar Labs 288316 1ct Handshield Diabetic Foot Cream 5oz 75026361005 Stanmar Labs 769919 1ct Burn-N-Bite Gel 2oz 75026390002 Stanmar Labs 163287 1ct Fosinopril Tab 40mg 90ct 30093722498 Teva Pharma 808972 1ct Buprenorphine 20mcg/hr TD Patch 4ct 30093360340 Teva Pharma 766881 1ct Methocarbamol Tab 500mg 100ct 36954313410 Virtus/Delaware 766899 1ct Methocarbamol Tab 500mg 500ct 36954313450 Virtus/Delaware 766907 1ct Methocarbamol Tab 750mg 100ct 36954313510 Virtus/Delaware 766915 1ct Methocarbamol Tab 750mg 500ct 36954313550 Virtus/Delaware 578518 1ct Midazolam VL 1mg/ml 2ml 10x2ml 30641605710 West-Ward, Inc. 578567 1ct Midazolam VL 10mg/2ml 10x2ml 30641606310 West-Ward, Inc. 734590 1ct Divalproex Tab 250mg 500ct 36838203205 Zydus Spartanburg, SC & Valdosta, GA Paragould, AR Toll Free 800-572-1216 Toll Free 866-346-9147 6/11/2018 Discontinued Items ct Smith # Sz Description NDC/UPC Manufacturer 653519 1ct 21st Cent Calcium 500mg+D 400ct 74098527522 21st Century 700997 1ct 21st Cent Colostrum 120ct 74098522891 21st Century 535278 1ct 21st Cent Glucosamine 1000mg 240ct 74098523018 21st Century 740787 1ct 21st Cent Vitajoy Daily D 120ct 74098527622 21st Century 740894 1ct 21st Cent Vitajoy Omega+DHA 120ct 74098527624 21st Century 571851 1ct 21st Cent Vit D 400IU Orange 110ct 74098527380 21st Century 423145 1ct Acetasol HC Ear Drops 10ml 30472088282 Actavis/Teva 563007 1ct PCE Dispertab 333mg 60ct 32433811260 Arbor Pharma 566026 1ct PCE Tablets 500mg 100ct 32433811413 Arbor Pharma 646570 1ct Prenate AM Prenatal Vit 30ct 37585430730 Avion Pharma 502120 1ct Dep Sport Endurance Gel 12oz 04167010164 Central Sales 076836 1ct Arm/Hammer TP Tooth Whitener 2.5oz 03320018581 Church&Dwight 541599 1ct First Hydrocortisone Gel Kit 60gm 36562801001 Cutis Pharma 614958 1ct Neutr Pore Refin Daily Cleans 6.7oz 07050105635 Dot Foods, Inc. 299529 1ct Dove Dry Roll On AP Pwd 2.5oz 07940050460 Dot Foods, Inc. 634444 1ct Playtex Glove Handsave XL 07830006332 Dot Foods, Inc. 782417 1ct Carisoprodol W/Asp Tb 200/325 100ct 32315514501 Heritage Pharma 639252 1ct Zolmitriptran ODT Tab 5mg 3’s 30115069250 Impax Generics 671198 1ct Haloperidol Tab 1mg UD 100ct 30904592361 Major Pharma 684001 1ct Aspirin EC Low Dose Tab 81mg 1000ct 30536100410 Major/Rugby 508143 1ct Ludens C Drop Honey/Lem Bag 30ct 81483201041 Medtech Labs 773770 1ct NV Veteran’s Pack Box 30pk 07985404066 National Vit 652511 1ct Ranitidine Tab 75mg 30ct 05166035230 Ohm Laboratories 652529 1ct Ranitidine Tab 75mg 60ct 05166035260 Ohm Laboratories 525980 1ct Benztropine Tab 1mg 100ct 30603243421 Par Pharma 803676 1ct Advil Menstrual Pain 20’s 30573023020 Pfizer Consumer 171603 1ct Pepto Bismol Max Chry Liq 8oz 30149085601 Procter & Gamble 671917 1ct Trv Sz Old Spice B/Wash Sport 3oz 03700086425 Procter & Gamble 556068 1ct Prodigy Safety Lancets 100ct 38484082026 Prodigy Diabetes 706564 1ct KY Love Couples Lubricant 1.69oz 06798193442 Reckitt Benckiser 641308 1ct Move Free One Softgel 30ct 02052511780 Reckitt Benckiser 825752 1ct RS Teacher Bar Solid 22x2z 07726004281 Russell Stover 699272 1ct RS Monkey’s Heart 18x1.75oz 10077260062861 Russell Stover 707455 1ct Alevicyn Antipruritic Gel 170gm 86026700011 Sonoma Pharma 096404 1ct Divalproex DR 125mg 100ct 30093743901 Teva Pharma 812560 1ct Renu Adv Multi Purp Sol 12oz 31011904303 Valeant Pharma 143255 1ct Gris Peg Tablets 125mg 100ct 30884076304 Valeant Pharma 251660 1ct Gris Peg Tablets 250mg 100ct 30884077304 Valeant Pharma Spartanburg, SC & Valdosta, GA Paragould, AR Toll Free 800-572-1216 Toll Free 866-346-9147 6/11/2018 Discontinued Items ct Smith # Sz Description NDC/UPC Manufacturer 609651 1ct Vicodin Tab 5/300mg 100ct 30074304113 Annvie US LLC 451013 1ct Estropipate Tab 1.5mg 100ct 30591041501 Actavis/Teva 665638 1ct Mirtazapine ODT 30mg 30ct 30591247015 Actavis/Teva 644088 1ct VP Great Scents Refr Waterfall 12x9z 04815592812 Delta Brands 756999 1ct VP Acne Treatment Pads 12x40ct 04815593009 Delta Brands 557983 1ct Pedicare Fev/Pain Cherry Inf 2oz 81483201166 Emerson 835991 1ct Er Recharger 1hr CH1 4pk 03980012883 Energizer Battery 524512 1ct Freeze It Pain Rel Feet Roll On 3z 85656900207 Expedite Products 524504 1ct Freeze It Xtreme Roll On 3oz 85656900208 Expedite Products 783241 1ct Phentermine Cap 30mg 1000ct 36931520310 Leading Pharma 722819 1ct Oxycodone Tab 15mg 100ct 36830811101 Mayne/Exel 722827 1ct Oxycodone Tab 30mg 100ct 36830811201 Mayne/Exel 732289 1ct Nicorelief Gum 2mg 50ct 30904573451 Major Pharma 738765 1ct Hydroskin Lot 1% 4oz 30536107997 Major/Rugby 831610 1ct Dexamethasone Tab 6mg 100ct 34988437301 Par Pharma 370254 1ct GS Cetirizine-D Tab 12ct 37003014848 Perrigo 427534 1ct GS Cetirizine-D Tab 24ct 37003014849 Perrigo 238683 1ct Oral B Orthodontic Brush Reg 30041802615 Procter & Gamble 834556 1ct Clonazepam Tab 0.5mg 100ct 30781801801 Sandoz 836189 1ct Clonazepam Tab 0.5mg 1000ct 30781801810 Sandoz 813220 1ct Clonazepam Tab 1mg 100ct 30781556701 Sandoz 813246 1ct Clonazepam Tab 1mg 500ct 30781556705 Sandoz 830679 1ct Clonazepam Tab 2mg 500ct 30781556905 Sandoz 321471 1ct Gum Actival Soft 07094212452 Sunstar Americas 349589 1ct 10hr Insect Repellent Spray 2oz 08392600006 Tec Laboratories 691212 1ct Lice Free 2n1 Cond/Shampoo 8oz 08392624500 Tec Laboratories 771493 1ct Tecnu Bites & Stings Wipes 20ct 08392615100 Tec Laboratories 216697 1ct Divalproex DR 250mg Tab 100ct 30093744001 Teva Pharma 159939 1ct Divalproex DR 500mg Tab 100ct 30093744101 Teva Pharma 158063 1ct Divalproex DR 500mg Tab 500ct 30093744105 Teva Pharma 158899 1ct Labetalol Tab 100mg 500ct 30172436470 Teva Pharma 158931 1ct Labetalol Tab 200mg 500ct 30172436570 Teva Pharma 136309 1ct Clonazepam Tab .5mg 100ct 30093083201 Teva Pharma 534156 1ct Clonazepam Tab .5mg 1000ct 30093083210 Teva Pharma 534180 1ct Clonazepam Tab 2mg
Load more

Recommended publications
  • Pfizer's Bourla
    No. 3985 December 13, 2019 line success and business development. “In the next two years, we need to see how the pipeline is delivering,” he said. Bourla has been outspoken that when it comes to business development, he doesn’t see a mega-merger on the hori- zon. Instead, he said he is looking to bring in mid-stage clinical development assets to complement the internal pipeline. It sounds like investors can expect the company to be active on the business development front within those guard- rails. “I want to double it,” he said of the pipeline, which includes 92 projects right now. “And, we are going to double it by bringing in a lot of innovation to comple- ment what we distribute.” The company is focusing business de- velopment on six core therapeutic areas Pfizer’s Bourla: “I Think We Forgot as well, but Bourla indicated the company will be actively building out those areas both through internal investment and What It Looks Like To Grow” external collaboration. “We’re going to be JESSICA MERRILL [email protected] active because Pfizer is a very big plane and it cannot fly with one engine,” he said. fizer Inc. CEO Albert Bourla took in July it will merge the Upjohn business Bourla highlighted Pfizer’s recent acqui- over the top leadership spot from with Mylan NV to form a new generic drug sition of the cancer specialist Array Bio- PIan Read a year ago, but has quickly company to be called Viatris GMBH. Pharma for $11.4bn as an example of the executed on big changes poised to make The resulting Pfizer will be significantly kinds of deals the company will be pursu- Pfizer significantly smaller and faster smaller, with a 2020 annual revenue base ing.
    [Show full text]
  • Health Industry Business Communications Council
    Health Industry Business Communications Council Registered Labelers: Accredited Auto-ID Labeling Standards Argentina New MedTek Devices Pty Ltd Oxavita SRL Norseld Pty Ltd. Novadien Healthcare Pty Ltd The following companies Odontit S.A. (and/or their subsidiaries/ PAMPAMED S.R.L. Numedico Technologies Pty Ltd divisions) have applied PATEJIM SRL Opto Global Pty. Ltd. for a Labeler Identification Orthocell Limited Code (LIC) assignment with Austria Prolotus Technologies Pty Ltd HIBCC*. By doing so, they afreeze GmbH Red Milawa Pty Ltd dba Magic Mobility have demonstrated their AMI GmbH SDI Limited commitment to patient safety Bender Medsystems GmbH Signostics Ltd. and logistical efficiency for BHS Technologies GmbH Sirtex Medical Pty Ltd their customers, the industry Metasys Medizintechnik GmbH Smith & Nephew Surgical Pty. Ltd. and the public at large. PAA Laboratories GmbH Staminalift International Limited Safersonic Medizinprodukte Handels The Pipette Company Pty. Ltd. Any organization that is GmbH Thermo Electron Corporation interested in using the HIBC W & H Dentalwerk Burmoos GmbH Vush Pty Ltd uniform labeling system may apply for the assignment of VUSH STIMULATION Australia one or more LICs. William A Cook Australia Pty. Ltd. Adv. Surgical Design & Manufacture, Ltd. Last updated 9-21-2021 AirPhysio Pty Ltd Belgium Annalise-AI Pty Ltd 3M Europe Apollo Medical Imaging Technology Pty Advanced Medical Diagnostics SA/NV Ltd Analis SA/NV Benra Pty Ltd dba Gelflex Laboratories Baxter World Trade Bioclone Australia Pty. Ltd. Bio-Rad RSL Candelis, Inc. Bio-Rad Lab Inc Clinical Diag. Group DePuy Australia Pty. Ltd. Biosource Europe SA For more information, please dorsaVi Ltd Cilag NV contact the HIBCC office at: EC Certification Service GmbH Coris Bioconcept Fink Engineering Pty Ltd Fuji Hunt Photographic Chemicals NV 2525 E.
    [Show full text]
  • Active Labelers List Labeler ID Labeler Name Begin Date End Date 00002 ELI LILLY and COMPANY 01/01/1991 12/31/2078 00003 E.R
    Kentucky Medicaid Pharmacy 3Q2011 Active Labelers List Labeler ID Labeler Name Begin Date End Date 00002 ELI LILLY AND COMPANY 01/01/1991 12/31/2078 00003 E.R. SQUIBB & SONS, INC. 01/01/1991 12/31/2078 00004 HOFFMANN-LA ROCHE 01/01/1991 12/31/2078 00005 LEDERLE LABORATORIES 01/01/1991 12/31/2078 00006 MERCK & CO., INC. 01/01/1991 12/31/2078 00007 GLAXOSMITHKLINE 01/01/1991 12/31/2078 00008 WYETH LABORATORIES 01/01/1991 12/31/2078 00009 PFIZER, INC 01/01/1991 12/31/2078 00013 PFIZER, INC. 01/01/1991 12/31/2078 00014 PFIZER, INC 01/01/1991 12/31/2078 00015 MEAD JOHNSON AND COMPANY 01/01/1991 12/31/2078 00023 ALLERGAN INC 01/01/1991 12/31/2078 00024 SANOFI-AVENTIS, US LLC 01/01/1991 12/31/2078 00025 PFIZER, INC. 01/01/1991 12/31/2078 00026 BAYER CORPORATION PHARMACEUTICAL DIV. 01/01/1991 12/31/2078 00028 NOVARTIS 01/01/1991 10/01/2011 00029 GLAXOSMITHKLINE 01/01/1991 12/31/2078 00031 A. H. ROBINS 01/01/1991 12/31/2078 00032 SOLVAY PHARMACEUTICALS, INC. 01/01/1991 12/31/2078 00037 MEDA PHARMACEUTICALS, INC. 01/01/1991 12/31/2078 00039 SANOFI-AVENTIS, US LLC 01/01/1991 12/31/2078 00045 ORTHO-MCNEIL-JANSSEN PHARMECEUTICAL, IN 01/01/1991 12/31/2078 00046 AYERST LABORATORIES 01/01/1991 12/31/2078 00049 PFIZER, INC 01/01/1991 12/31/2078 00051 UNIMED PHARMACEUTICALS, INC 10/01/1997 12/31/2078 00052 ORGANON USA INC.
    [Show full text]
  • PFIZER INC. (Exact Name of Registrant As Specified in Its Charter)
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-3619 PFIZER INC. (Exact name of registrant as specified in its charter) Delaware 13-5315170 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 235 East 42nd Street, New York, New York 10017 (Address of principal executive offices) (zip code) (212) 733-2323 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.05 par value PFE New York Stock Exchange 0.000% Notes due 2020 PFE20A New York Stock Exchange 0.250% Notes due 2022 PFE22 New York Stock Exchange 1.000% Notes due 2027 PFE27 New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • UNITED NATIONS SYSTEM Annual Statistical Report 2005
    Annual Statistical Report 2005 • Procurement of Goods & Services • All Sources of Funding • UNDP Funding • Procurement from DAC Member Countries • International & National Project Personnel • United Nations Volunteers • Fellowships Published: July 2006 by UNITED NATIONS SYSTEM Annual Statistical Report 2005 Procurement of Goods and Services • All Sources of Funding • UNDP Funding Procurement from DAC Member Countries International & National Project Personnel United Nations Volunteers Fellowships July 2006 Copyright © 2006 by the United Nations Development Programme 1 UN Plaza, New York, NY 10017, USA All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic, photocopying, recording or otherwise, without prior permission of UNDP/IAPSO. TABLE OF CONTENTS INTRODUCTION...................................................................................................................... 1 GLOASSARY OF TERMS ...................................................................................................... 3 EXECUTIVE SUMMARY: ALL SOURCES OF FUNDING (UN SYSTEM)............................ 4 PROCUREMENT OF GOODS AND SERVICES - ALL SOURCES OF FUNDING Procurement of goods by country of procurement and services by country of head office ................................................................................................... 9 Procurement by UN agency ......................................................................................
    [Show full text]
  • FTSE Developed
    2 FTSE Russell Publications 19 August 2021 FTSE Developed Indicative Index Weight Data as at Closing on 30 June 2021 Index weight Index weight Index weight Constituent Country Constituent Country Constituent Country (%) (%) (%) 1&1 AG <0.005 GERMANY Alcon AG 0.05 SWITZERLAND Aozora Bank <0.005 JAPAN 3i Group 0.03 UNITED Ald SA <0.005 FRANCE APA Group 0.01 AUSTRALIA KINGDOM Alexandria Real Estate Equity 0.04 USA Appen <0.005 AUSTRALIA 3M Company 0.19 USA Alexion Pharm 0.07 USA Apple Inc. 3.61 USA A P Moller - Maersk A 0.02 DENMARK Alfa Laval 0.02 SWEDEN Applied Materials 0.22 USA A P Moller - Maersk B 0.03 DENMARK Alfresa Holdings <0.005 JAPAN Aptiv PLC 0.07 USA a2 Milk 0.01 NEW ZEALAND Align Technology Inc 0.08 USA Aramark 0.01 USA A2A 0.01 ITALY Alimentation Couche-Tard B 0.05 CANADA Arcelor Mittal 0.04 NETHERLANDS AAC Technologies Holdings 0.01 HONG KONG Alleghany 0.02 USA Arch Capital Gp 0.03 USA Aalberts NV 0.01 NETHERLANDS Allegion PLC 0.02 USA Archer Daniels Midland 0.06 USA ABB 0.1 SWITZERLAND Allegro 0.01 POLAND Argenx S.E 0.03 BELGIUM Abbott Laboratories 0.34 USA Alliant Energy 0.02 USA Ariake Japan <0.005 JAPAN AbbVie Inc 0.33 USA Allianz SE 0.17 GERMANY Arista Networks 0.04 USA ABC-Mart <0.005 JAPAN Allstate Corp 0.07 USA Aristocrat Leisure 0.03 AUSTRALIA Abiomed Inc 0.02 USA Ally Financial 0.03 USA Arkema 0.01 FRANCE ABN AMRO Bank NV 0.01 NETHERLANDS Alnylam Pharmaceuticals 0.03 USA Aroundtown SA 0.02 GERMANY Accenture Cl A 0.31 USA Alony Hetz Properties & Inv <0.005 ISRAEL Arrow Electronics 0.01 USA Acciona S.A.
    [Show full text]
  • Participating Labelers.Xlsx
    Labeler Labeler Effective Labeler End Code Labeler Name Date Date 00002 ELI LILLY AND COMPANY 1/1/1991 12/31/2299 00003 E.R. SQUIBB & SONS, INC. 1/1/1991 12/31/2299 00004 HOFFMANN-LA ROCHE 1/1/1991 12/31/2299 00005 LEDERLE LABORATORIES 1/1/1991 12/31/2299 00006 MERCK & CO., INC. 1/1/1991 12/31/2299 00007 GLAXOSMITHKLINE 1/1/1991 12/31/2299 00008 WYETH LABORATORIES 1/1/1991 12/31/2299 00009 PFIZER, INC 1/1/1991 12/31/2299 00013 PFIZER, INC. 1/1/1991 12/31/2299 00015 MEAD JOHNSON AND COMPANY 1/1/1991 12/31/2299 00023 ALLERGAN INC 1/1/1991 12/31/2299 00024 SANOFI-AVENTIS, US LLC 1/1/1991 12/31/2299 00025 PFIZER, INC. 1/1/1991 12/31/2299 00026 BAYER CORPORATION PHARMACEUTICAL DIV. 1/1/1991 12/31/2299 00028 NOVARTIS 1/1/1991 12/31/2299 00029 GLAXOSMITHKLINE 1/1/1991 12/31/2299 00031 A. H. ROBINS 1/1/1991 12/31/2299 00032 SOLVAY PHARMACEUTICALS, INC. 1/1/1991 12/31/2299 00037 MEDA PHARMACEUTICALS, INC. 1/1/1991 12/31/2299 00039 SANOFI-AVENTIS, US LLC 1/1/1991 12/31/2299 00045 ORTHO-MCNEIL-JANSSEN PHARMECEUTICAL, IN 1/1/1991 12/31/2299 00046 AYERST LABORATORIES 1/1/1991 12/31/2299 00049 PFIZER, INC 1/1/1991 12/31/2299 00051 UNIMED PHARMACEUTICALS, INC 10/1/1997 12/31/2299 00052 ORGANON USA INC. 1/1/1991 12/31/2299 00053 CSL BEHRING 1/1/1991 12/31/2299 00054 ROXANE LABORATORIES, INC.
    [Show full text]
  • UNITED NATIONS SYSTEM Annual Statistical Report 2005
    Annual Statistical Report 2005 • Procurement of Goods & Services • All Sources of Funding • UNDP Funding • Procurement from DAC Member Countries • International & National Project Personnel • United Nations Volunteers • Fellowships Published: July 2006 by UNITED NATIONS SYSTEM Annual Statistical Report 2005 Procurement of Goods and Services • All Sources of Funding • UNDP Funding Procurement from DAC Member Countries International & National Project Personnel United Nations Volunteers Fellowships July 2006 Copyright © 2006 by the United Nations Development Programme 1 UN Plaza, New York, NY 10017, USA All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic, photocopying, recording or otherwise, without prior permission of UNDP/IAPSO. TABLE OF CONTENTS INTRODUCTION...................................................................................................................... 1 GLOASSARY OF TERMS ...................................................................................................... 3 EXECUTIVE SUMMARY: ALL SOURCES OF FUNDING (UN SYSTEM)............................ 4 PROCUREMENT OF GOODS AND SERVICES - ALL SOURCES OF FUNDING Procurement of goods by country of procurement and services by country of head office ................................................................................................... 9 Procurement by UN agency ......................................................................................
    [Show full text]
  • Downloaded to a PC Or PDA
    DDT Issue10 NOVEMBER05 11/28/05 4:27 PM Page 1 NOVEMBER/DECEMBER 2005 Vol 5 No 10 IN THIS ISSUE Corporate Profiles 12 Drug Delivery Technologies 76 Excipients, Polymers, Liposomes & Lipids 92 Contract Pharmaceutical & Biological Development Services 98 Laboratory Testing & Analytical Equipment & Sotware 109 Technology Spotlight 113 The science & business of specialty pharma, biotechnology, and drug delivery www.drugdeliverytech.com DDT Issue10 NOVEMBER05 11/7/05 3:41 PM Page 2 NO BARRIERS. NEW FRONTIERS. COMPLEX CHALLENGES, INNOVATIVE SOLUTIONS. For 35 years, ALZA has led the drug delivery industry in developing extraordinary products based on our transdermal, oral, implantable, and liposomal delivery platforms. More than 30 products in 80 countries are based on ALZA’s novel drug delivery and targeting technologies. Today, ALZA’s dedicated researchers and scientists are addressing the complex challenges of delivering small molecules and biopharmaceuticals, with the commitment to create better medicines that improve healthcare for patients worldwide. Visit www.alza.com to learn more. © 2003 ALZA Corporation LEADING THE NEXT GENERATION OF DRUG DELIVERY DDT Issue10 NOVEMBER05 11/5/05 8:12 AM Page 3 Inhalation and transdermal technology from 3M w Novel Dry Powder Inhaler Ne Gives you the edge in a from MicroDose Technologiescompetitive environment The MicroDose dry powder inhaler, CFC-free metered dose inhaler and transdermal drug delivery systems customized to your specifications ៑ A wide variety of components to meet your needs ៑ Nearly 50 years’ experience in inhalation drug delivery technology and skin adhesion products ៑ Fully integrated development and manufacturing processes ៑ Global regulatory expertise ៑ Project management support available from concept through commercialization Developing proven solutions that enable your success.
    [Show full text]
  • 2019 MED-Project Annual Report
    2019 MED-Project Annual Report Alameda County, California March 1, 2020 Prepared By: MED-Project LLC Submitted To: Alameda County, Department of Environmental Health Table of Contents Executive Summary ............................................................................................................. 4 Participating Producers ....................................................................................................... 5 Collection Method and Weight ............................................................................................ 5 A. Kiosks .................................................................................................................................... 5 B. Mail-Back Packages ................................................................................................................. 5 C. Take-Back Events ................................................................................................................... 5 D. Total Weight of Collected Unwanted Medicine ........................................................................... 5 Kiosk Drop-Off Locations, Mail-Back Distribution, and Take-Back Events ......................... 5 Kiosk Drop-Off Locations ......................................................................................................... 6 Mail-Back Package Distribution Locations .................................................................................. 6 Number of Mail-Back Packages Provided to Home-Bound and Under Served Residents ...............
    [Show full text]
  • Drug Companies Participating in MED-Project Stewardship Plan (February 9, 2017)
    Drug Companies Participating in MED-Project Stewardship Plan (February 9, 2017) Participating Drug Company Parent Drug Company 3M Corporation 3M Corporation 3M Critical and Chronic Care 3M Corporation 3M Drug Delivery Systems 3M Corporation 3M Infection Prevention 3M Corporation 3M Oral Care 3M Corporation AbbVie Inc. AbbVie Inc. ACADIA Pharmaceuticals Inc. ACADIA Pharmaceuticals Inc. Accord Healthcare Inc. Accord Healthcare Inc. Acorda Therapeutics, Inc. Acorda Therapeutics, Inc. Acorda Therapeutics, Inc. Acorda Therapeutics, Inc. Actavis Generics Teva Pharmaceuticals USA, Inc. Actavis Pharma, Inc. (only for labeler code 52544) Allergan, Inc. Actelion Pharmaceuticals US, Inc. Actelion Pharmaceuticals US, Inc. Advanced Vision Research Inc. d.b.a. Akorn Consumer Health Akorn, Inc. Aegerion Pharmaceuticals, Inc. Aegerion Pharmaceuticals, Inc. Afaxys Inc. Afaxys Inc. Afaxys Pharmaceuticals (a division of Afaxys Inc.) Afaxys Inc. Affordable Pharmaceuticals LLC Braintree Laboratories Inc. Akorn Animal Health, Inc. Akorn, Inc. Akorn, Inc. Akorn, Inc. Akrimax Pharmaceuticals, LLC Akrimax Pharmaceuticals, LLC AKRON COATING & ADHESIVES AKRON COATING & ADHESIVES Alcon Laboratories, Inc. Novartis Group Companies Allergan Sales LLC Allergan, Inc. Allergan USA, Inc. Allergan, Inc. Allergan, Inc. Allergan, Inc. Alva-Amco Pharmacal Companies, Inc. Alva-Amco Pharmacal Companies, Inc. AMAG Pharma USA, Inc. AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. Amarin Corp Amarin Pharma, Inc. Amarin Corp. PLC Amarin Pharma, Inc. Amarin Pharma, Inc. Amarin Pharma, Inc. Amarin Pharmaceuticals Ireland Ltd. Amarin Pharma, Inc. American Regent, Inc. Daiichi Sankyo, Inc. Amerisource Health Services Corporation DBA: American Health Amerisource Health Services Corporation DBA: American Health Packaging Packaging Amgen Inc. Amgen Inc. Amgen USA Amgen Inc. Amneal Pharmaceuticals LLC Amneal Pharmaceuticals LLC Anchen Pharmaceuticals, Inc.
    [Show full text]
  • Washington State 2020 Annual Report (PDF)
    First MED-Project Annual Report For 2019 Operating Period State of Washington Due July 1, 2020 Prepared By: MED-Project WA, LLC Submitted To: Washington State Department of Health Table of Contents I. Executive Summary ............................................................................................................... 3 II. Annual Budget ...................................................................................................................... 3 Table 1: Annual Budget .................................................................................................................. 4 Appendix A ................................................................................................................................ 5 List of Covered Manufacturers ......................................................................................................... 5 Table 2: List of Covered Manufacturers.......................................................................................... 21 2 I. Executive Summary MED-Project WA, LLC’s (“MED-Project”) Product Stewardship Plan for Covered Drugs from Households (“Plan”) was approved by the Washington State Department of Health (the "Department") on May 25, 2020. Per the Plan, MED-Project will initiate operations by November 21, 2020, which is within 180 days of the Plan approval date. This first Annual Report for the 2019 reporting period was requested by the Department and includes an update to the annual budget that occurred after the submission of the proposed Plan and
    [Show full text]